FAKTOR-OPTIONSSCHEIN - ROCHE GS Share Price

Certificat

DE000MF1FUH8

Market Closed - Börse Stuttgart 19:39:26 14/06/2024 BST
1.15 EUR +0.88% Intraday chart for FAKTOR-OPTIONSSCHEIN - ROCHE GS
Current month+43.75%
1 month+57.53%
Date Price Change
14/06/24 1.15 +0.88%
13/06/24 1.14 +5.56%
12/06/24 1.08 +3.85%
11/06/24 1.04 +5.05%
10/06/24 0.99 -2.94%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 07:39 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Morgan Stanley
WKN MF1FUH
ISINDE000MF1FUH8
Date issued 01/02/2017
Strike 196.7 CHF
Maturity Unlimited
Parity 45 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 40.73
Lowest since issue 0.58

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
247.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+12.30%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW